My bookmarksSign up free

Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Regulation (EU) 2022/1255 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Antimicrobials or groups of antimicrobials designated as reserved for treatment of certain infections in humans

Article 1

1.   The antimicrobials and groups of antimicrobials listed in the Annex shall not be used in veterinary medicinal products or medicated feed. 2.   The use in animals of medicinal products for human use that contain any of the antimicrobials or groups of antimicrobials listed in the Annex is prohibited.

Entry into force and application

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 9 February 2023.

Supplementary provisions

Antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans

ANNEXSupplementary provisions

ANNEX Antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans (1)    Antibiotics (a) Carboxypenicillins (b) Ureidopenicillins (c) Ceftobiprole (d) Ceftaroline (e) Combinations of cephalosporins with beta-lactamase inhibitors (f) Siderophore cephalosporins (g) Carbapenems (h) Penems (i) Monobactams (j) Phosphonic acid derivates (k) Glycopeptides (l) Lipopeptides (m) Oxazolidinones (n) Fidaxomicin (o) Plazomicin (p) Glycylcyclines (q) Eravacycline (r) Omadacycline (2)    Antivirals (a) Amantadine (b) Baloxavir marboxil (c) Celgosivir (d) Favipiravir (e) Galidesivir (f) Lactimidomycin (g) Laninamivir (h) Methisazone/metisazone (i) Molnupiravir (j) Nitazoxanide (k) Oseltamivir (l) Peramivir (m) Ribavirin (n) Rimantadine (o) Tizoxanide (p) Triazavirin (q) Umifenovir (r) Zanamivir (3)    Antiprotozoals (a) Nitazoxanide

Other acts of the same type
Commission Implementing Regulation (EU) 2021/724 of 3 March 2021 laying down rules for the application of Regulation (EU) 2019/787 of the European Parliament and of the Council as regards the communications to be made by Member States to the Commission with regard to the bodies appointed to supervise ageing processes for spirit drinks and the competent authorities responsible for ensuring compliance with that RegulationCouncil Implementing Regulation (EU) 2021/371 of 2 March 2021 implementing Regulation (EU) 2020/1998 concerning restrictive measures against serious human rights violations and abusesCommission Implementing Regulation (EU) 2021/367 of 1 March 2021 concerning the renewal of the authorisation of a preparation of Saccharomyces cerevisiae CNCM I-4407 as a feed additive for calves for rearing and repealing Regulation (EU) No 883/2010 (holder of authorisation S.I. Lesaffre) (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/368 of 1 March 2021 granting a Union authorisation for the single biocidal product ‘Aero-Sense Aircraft Insecticide ASD’ (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/369 of 1 March 2021 establishing the technical specifications and procedures required for the system of interconnection of central registers referred to in Directive (EU) 2015/849 of the European Parliament and of the Council (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/930 of 1 March 2021 supplementing Regulation (EU) No 575/2013 of the European Parliament and of the Council with regard to regulatory technical standards specifying the nature, severity and duration of an economic downturn referred to in Article 181(1), point (b), and Article 182(1), point (b), of that Regulation (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/931 of 1 March 2021 supplementing Regulation (EU) No 575/2013 of the European Parliament and of the Council with regard to regulatory technical standards specifying the method for identifying derivative transactions with one or more than one material risk driver for the purposes of Article 277(5), the formula for calculating the supervisory delta of call and put options mapped to the interest rate risk category and the method for determining whether a transaction is a long or short position in the primary risk driver or in the most material risk driver in the given risk category for the purposes of Article 279a(3)(a) and (b) in the standardised approach for counterparty credit risk (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/363 of 26 February 2021 concerning the authorisation of a preparation of fumonisin esterase produced by Komagataella phaffii DSM 32159 as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/364 of 26 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product-type 1 (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/365 of 26 February 2021 approving active chlorine released from hypochlorous acid as an active substance for use in biocidal products of product-type 1 (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/704 of 26 February 2021 amending Regulation (EU) 2018/196 of the European Parliament and of the Council on additional customs duties on imports of certain products originating in the United States of AmericaCommission Delegated Regulation (EU) 2021/723 of 26 February 2021 supplementing Regulation (EU) 2019/787 of the European Parliament and of the Council as regards the setting up of a public register listing the bodies appointed by each Member State to supervise the ageing processes for spirit drinks

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview